Open AccessCommentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response
Author(s) -
André De Souza,
Fabio Tavora,
Devalingam Mahalingam,
Pamela N. Münster,
Howard Safran,
Wafik S. ElDeiry,
Benedito A. Carneiro
Publication year - 2020
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/fimmu.2020.595289
Subject(s) - immune system , viral replication , virology , replication (statistics) , dual (grammatical number) , covid-19 , immunology , biology , medicine , virus , philosophy , infectious disease (medical specialty) , linguistics , disease , pathology